These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16614160)

  • 41. Budd-Chiari syndrome: Radiologic findings.
    Kamath PS
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S21-2. PubMed ID: 17051559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evaluation of mesoatrial shunt patency with computed tomography.
    Fishman EK; Siegelman SS; Cameron JL
    Surgery; 1985 Jan; 97(1):60-5. PubMed ID: 3966230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transjugular Intrahepatic Portosystemic Shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis.
    Senzolo M; Cholongitas E; Davies N; Marelli L; Shusang V; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Sep; 101(9):2163-4; author reply 2164-5. PubMed ID: 16968512
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acute Budd-Chiari syndrome--successful treatment based on TIPSS].
    Wildberger JE; Winograd R; Wingen M; Busch N; Vorwerk D
    Rofo; 1998 Apr; 168(4):393-6. PubMed ID: 9589105
    [No Abstract]   [Full Text] [Related]  

  • 45. Transjugular intrahepatic portosystemic shunt in combination with oral anticoagulant for Budd-Chiari syndrome.
    Seki S; Sakaguchi H; Kobayashi S; Kitada T; Nakamura K; Yamada R
    Hepatogastroenterology; 2001; 48(41):1447-9. PubMed ID: 11677983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Budd-Chiari syndrome illustrated by four case reports].
    Grønbaek H; Nielsen DT; Astrup LB
    Ugeskr Laeger; 2002 Jun; 164(25):3360-3. PubMed ID: 12107952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experience with mesocaval shunt with autologous jugular vein interposition in patients with Budd-Chiari syndrome.
    Ilkgul O; Kilic M; Içöz G; Zeytunlu M; Demirpolat G; Akyildiz M; Tokat Y; Parildar M; Memis A
    Hepatogastroenterology; 2005; 52(63):662-5. PubMed ID: 15966177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chronic radiodermatitis after a transjugular intrahepatic portosystemic shunt].
    Cante V; Doutre MS
    Ann Dermatol Venereol; 2011 May; 138(5):424-5. PubMed ID: 21570570
    [No Abstract]   [Full Text] [Related]  

  • 49. Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt.
    Das HS; Punamiya S; Kalokhe S; Desai N; Amarapurkar D; Sawant P
    J Assoc Physicians India; 2003 Mar; 51():309-10. PubMed ID: 12839361
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical decision making in acute Budd Chiari Syndrome.
    McKnight L; Chandok N; Hernandez-Alejandro R
    Ann Hepatol; 2010; 9(4):473-4. PubMed ID: 21057171
    [No Abstract]   [Full Text] [Related]  

  • 51. Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome.
    Madhusudhan KS; Sharma S
    AJR Am J Roentgenol; 2021 May; 216(5):W15. PubMed ID: 33729877
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt.
    Blokzijl H; de Knegt RJ
    Hepatology; 2002 Jun; 35(6):1551-2. PubMed ID: 12029648
    [No Abstract]   [Full Text] [Related]  

  • 53. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.
    Perelló A; García-Pagán JC; Gilabert R; Suárez Y; Moitinho E; Cervantes F; Reverter JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 2002 Jan; 35(1):132-9. PubMed ID: 11786969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TIPS for Budd-Chiari syndrome: time to anticipate treatment.
    Mancuso A
    Liver Int; 2014 Aug; 34(7):e325. PubMed ID: 24650135
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion.
    Airoldi A; Vangeli M; Vizzutti F; Pinzani M; Minola E; Rampoldi A; Pinzello G
    Liver Int; 2009 Sep; 29(8):1288-9. PubMed ID: 19515219
    [No Abstract]   [Full Text] [Related]  

  • 57. Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome.
    Tanju S; Erden A; Ceyhan K; Soygür IT; Bozkaya H; Erden I
    Turk J Gastroenterol; 2004 Sep; 15(3):173-7. PubMed ID: 15492917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous transjugular direct porto-caval shunt in patients with Budd-Chiari syndrome.
    Quateen A; Pech M; Berg T; Bergk A; Podrabsky P; Felix R; Ricke J
    Cardiovasc Intervent Radiol; 2006; 29(4):565-70. PubMed ID: 16729230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of Budd-Chiari syndrome successfully treated by transcatheter recanalization of the right hepatic vein and transjugular intrahepatic portosystemic shunt.
    Yamada K; Nakamura K; Ogawa K; Kuroki S; Yamashita A; Morimoto A; Kaminou T; Yamada R
    Radiat Med; 1999; 17(1):85-9. PubMed ID: 10378659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction.
    Watanabe H; Shinzawa H; Saito T; Ishibashi M; Shirahata N; Miyano S; Haga H; Aoki M; Mitsuhashi H; Matsuo T; Abe T; Saito K; Yamada N; Togashi H; Takahashi T
    Hepatogastroenterology; 2000; 47(33):839-41. PubMed ID: 10919043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.